Recruitment Fraud Notice

Slate Run
News

A Generics Provider You Can Rely On

Get In Touch

Arna Pharma Inc. and Slate Run Pharmaceuticals Finalize Joint Venture and Launch First Brand Product

AUSTIN, Texas, May 14, 2026 /PRNewswire/ — Arna Pharma Inc. and Slate Run Pharmaceuticals today announced they have finalized their joint venture to create a scaled-up U.S.-based specialty pharmaceutical company focused on branded products, 505(b)(2) medicines, and specialized generics. The companies are also launching their first brand product together, Aridol®, with additional

Read More »

Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture

AUSTIN, Texas – Feb 21st, 2026, Arna Pharma Inc. and Slate Run Pharmaceuticals announced they have signed an MOU to create a scaled-up U.S.-based specialty pharmaceutical joint venture focused on branded products, 505(b)(2) medicines, and specialized generics. The joint venture brings together Arna Pharma’s development capabilities and portfolio expansion strategy with Slate

Read More »

We have been made aware of recent scams that offer false employment opportunities or request financial commitments purportedly on behalf of Slate Run Pharmaceuticals. Unsuspecting job seekers have reported receiving unsolicited contacts such as e-mails and phone calls which may request personal information or offers of employment. Please note that these communications are fraudulent and are not affiliated with Slate Run Pharmaceuticals. Slate Run Pharmaceuticals never requires a financial deposit for employment consideration nor do we offer unsolicited employment packages.

You can reach out to Slate Run Pharmaceuticals at http://www.slaterunpharma.com/get-in-touch/. If you receive a suspicious proposal, please contact your local law enforcement agency for guidance.